Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
27.66
-0.11 (-0.40%)
At close: Sep 11, 2026, 4:00 PM EDT
27.89
+0.23 (0.83%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Alamar Biosciences Employees
Alamar Biosciences had 286 employees as of June 30, 2026.
Employees
286
Change
n/a
Growth
n/a
Revenue / Employee
$351,119
Profits / Employee
-$173,640
Market Cap
1.94B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 286 | - | - |
| Mar 31, 2026 | 250 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UFP Technologies | 4,846 |
| CONMED | 3,900 |
| Neogen | 2,636 |
| Tandem Diabetes Care | 2,500 |
| NovoCure | 1,605 |
| Inspire Medical Systems | 1,333 |
| Establishment Labs Holdings | 1,004 |
| Alphatec Holdings | 913 |
ALMR News
- 12 days ago - Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Alamar Biosciences price target raised to $31 from $30 at BofA - TheFly
- 4 weeks ago - Alamar Biosciences price target raised to $32 from $28 at Stifel - TheFly
- 4 weeks ago - Alamar Biosciences price target raised to $35 from $32 at JPMorgan - TheFly
- 4 weeks ago - Alamar Biosciences expands Alzheimer’s Data Initiative deal with 86K samples - TheFly
- 4 weeks ago - Alamar Biosciences reports Q2 EPS (22c), consensus (32c) - TheFly
- 4 weeks ago - Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M - TheFly
- 4 weeks ago - Alamar Biosciences Earnings Call Transcript: Q2 2026 - Transcripts